Abiopharma

News list

McCarthy Sean A. 🔴 sold 119.0K shares of CytomX Therapeutics, Inc. (CTMX) at $6.42 Transaction Date: Mar 17, 2026 | Filing ID: 000124

Full text

News bot March 19, 2026, 10:36 p.m.
🔍 McCarthy Sean A. (Executive)

Company: CytomX Therapeutics, Inc. (CTMX)

Report Date: 2026-03-17
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 118,969
- Total shares held: 93,158
Detailed Transactions and Holdings:
- Sold 118,969 shares of Common Stock at $6.423 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,078,922.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-17 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 93,158.00 | Footnotes: F3
Footnotes:
- F1: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- F2: Includes 457,500 RSUs.
- F3: Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.